AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2019
Aug 1, 2019
33298_dirs_2019-08-01_348165d8-2fa9-476e-a8d7-421ca83d4cd9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONVERSION LABS, INC. (CVLB)
CIK: 0000948320
Period of Report: 2019-07-31
Reporting Person: Schreiber Justin (Director, Chief Executive Officer, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-07-31 | Common Stock, par value $0.01 | P | 50000 | $0.13 | Acquired | 6880695 | Indirect |
| 2019-08-01 | Common Stock, par value $0.01 | J | 2500000 | — | Acquired | 9380695 | Indirect |
Footnotes
F1: These shares were purchased on the open market.
F2: These shares were acquired via a transaction whereby the Reporting Person sold his remaining interests in Conversion Labs PR, LLC, a now wholly owned subsidiary of the Company, to the Company.
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17